视网膜基因治疗中局限性医源性黄斑脱离后的结构与功能恢复
这项前瞻性眼间对照研究纳入5例临床和基因诊断的脉络膜缺失症男性患者(23至71岁),单眼行视网膜下注射0.1 mL含1×10^11病毒颗粒的腺相关病毒载体(编码Rab护送蛋白1)造成医源性黄斑脱离。光学相干断层扫描显示全部5例患者在1周内医源性视网膜脱离完全消退,1个月时视力恢复或改善,但阈值敏感度和色觉辨别未见相应改善。
要点
- 全部5例患者在1周内医源性视网膜脱离完全消退。
- 1个月时治疗眼视力平均变化+5.4个字母,对照眼+0.8个字母。
- 1个月时阈值敏感度和FM 100色相检查的色觉辨别变化不大。
核心结论
- 以光学相干断层扫描评估的视网膜结构恢复在医源性脱离后不久即发生。
- 视力在术后1个月内恢复或改善,且可能不伴随阈值敏感度或色觉辨别的改善。
- 1例患者色匹配变化提示术后早期视锥光色素有效光密度降低。
研究设计与样本
- 前瞻性眼间对照研究,于2015年2月1日至12月31日进行。
- 治疗为单侧视网膜下注射0.1 mL含1×10^11病毒颗粒的基因治疗溶液。
- 参与者为5例临床和基因诊断的脉络膜缺失症男性,年龄23至71岁。
- 在基线、1周和1个月时使用光学相干断层扫描、logMAR视力、微视野、Farnsworth-Munsell(FM)100色相检查和Rayleigh匹配评估视网膜结构与功能。
主要发现
- 光学相干断层扫描图像显示全部5例患者在1周内医源性视网膜脱离完全消退。
- 1个月时中央黄斑厚度平均(SE)变化:治疗眼+9.6(7.2)μm,对照眼+8.8(12.6)μm。
- 1个月时视力平均(SE)变化:治疗眼+5.4(3.3)个字母,对照眼+0.8(3.1)个字母。
- 1个月时平均(SE)阈值敏感度变化:治疗眼-1.2(2.1)dB,对照眼-1.0(1.2)dB。
- 1个月时FM 100色相检查色觉辨别变化不大,C指数平均(SE)变化:治疗眼-0.2(0.4),对照眼0.1(0.2)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The early decline and recovery of retinal structure and function following iatrogenic macular detachment for retinal gene therapy is not well characterized in those with relatively preserved central visual function. Here, the recovery of retinal structure and function over the first month following iatrogenic retinal detachment for the delivery of adeno-associated viral vector encoding Rab Escort Protein 1 is described as a part of gene therapy for choroideremia. OBJECTIVE: To study changes in both retinal structure and function during the first month following iatrogenic macular detachment surgery. DESIGN, SETTING, AND PARTICIPANTS: This prospective interocularly controlled study was conducted between February 1 and December 31, 2015. Treatment consisted of a subretinal injection of 0.1 mL of a gene therapy solution containing 1 × 1011 viral particles performed unilaterally. The participants were 5 males, aged 23 to 71 years, with a clinical and genetic diagnosis of choroideremia. MAIN OUTCOMES AND MEASURES: Retinal structure and function were assessed at baseline, 1 week, and 1 month using optical coherence tomography, logMAR visual acuity, microperimetry, the Farnsworth-Munsell (FM) 100-hue test, and the Rayleigh match. RESULTS: Five white male patients aged 23 to 71 years underwent unilateral subretinal gene therapy for genetically confirmed choroidermeia. Optical coherence tomographic images demonstrated a complete resolution of the resulting iatrogenic retinal detachment by 1 week in all 5 patients. At 1 month, the mean (SE) change in central foveal thickness was +9.6 (7.2) μm in treated eyes and +8.8 (12.6) μm in control eyes. The mean (SE) change in visual acuity was +5.4 (3.3) letters in treated eyes and +0.8 (3.1) letters in control eyes. At 1 month, the mean (SE) threshold sensitivity changes were -1.2 (2.1) dB in treated eyes and -1.0 (1.2) dB in control eyes. Color discrimination at the FM 100-hue changed little at 1 month (mean [SE] change in C-index, -0.2 [0.4] in treated eyes and 0.1 [0.2] in control eyes). Rayleigh matches in 1 patient were consistent with a diagnosis of pseudoprotanomaly, suggesting decreased effective optical density of the cone photopigments. CONCLUSIONS AND RELEVANCE: Retinal structural recovery-as assessed by optical coherence tomography-occurs soon after iatrogenic detachment. Similarly, visual acuity recovers or improves within 1 month of the procedure and may not be accompanied by improvements in threshold sensitivity or color discrimination. Changes in color matching in 1 patient suggest decreased optical density of the cone photopigments in the early postoperative period.
引用
- Simunovic MP, Xue K, Jolly JK, et al. Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy. JAMA Ophthalmol. 2017. PMID: 28152124. doi:10.1001/jamaophthalmol.2016.5630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。